Literature DB >> 21030588

Structural basis for c-KIT inhibition by the suppressor of cytokine signaling 6 (SOCS6) ubiquitin ligase.

Fahad Zadjali1, Ashley C W Pike, Mattias Vesterlund, Jianmin Sun, Chenggang Wu, Shawn S C Li, Lars Rönnstrand, Stefan Knapp, Alex N Bullock, Amilcar Flores-Morales.   

Abstract

The c-KIT receptor tyrosine kinase mediates the cellular response to stem cell factor (SCF). Whereas c-KIT activity is important for the proliferation of hematopoietic cells, melanocytes and germ cells, uncontrolled c-KIT activity contributes to the growth of diverse human tumors. Suppressor of cytokine signaling 6 (SOCS6) is a member of the SOCS family of E3 ubiquitin ligases that can interact with c-KIT and suppress c-KIT-dependent pathways. Here, we analyzed the molecular mechanisms that determine SOCS6 substrate recognition. Our results show that the SH2 domain of SOCS6 is essential for its interaction with c-KIT pY568. The 1.45-Å crystal structure of SOCS6 SH2 domain bound to the c-KIT substrate peptide (c-KIT residues 564-574) revealed a highly complementary and specific interface giving rise to a high affinity interaction (K(d) = 0.3 μm). Interestingly, the SH2 binding pocket extends to substrate residue position pY+6 and envelopes the c-KIT phosphopeptide with a large BG loop insertion that contributes significantly to substrate interaction. We demonstrate that SOCS6 has ubiquitin ligase activity toward c-KIT and regulates c-KIT protein turnover in cells. Our data support a role of SOCS6 as a feedback inhibitor of SCF-dependent signaling and provides molecular data to account for target specificity within the SOCS family of ubiquitin ligases.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21030588      PMCID: PMC3013007          DOI: 10.1074/jbc.M110.173526

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  40 in total

1.  The tumor suppressor activity of SOCS-1.

Authors:  Robert Rottapel; Subburaj Ilangumaran; Christopher Neale; Jose La Rose; Jenny M-Y Ho; Melody H-H Nguyen; Dwayne Barber; Patrice Dubreuil; Paulo de Sepulveda
Journal:  Oncogene       Date:  2002-06-27       Impact factor: 9.867

Review 2.  Signal transduction via the stem cell factor receptor/c-Kit.

Authors:  L Rönnstrand
Journal:  Cell Mol Life Sci       Date:  2004-10       Impact factor: 9.261

3.  Muf1, a novel Elongin BC-interacting leucine-rich repeat protein that can assemble with Cul5 and Rbx1 to reconstitute a ubiquitin ligase.

Authors:  T Kamura; D Burian; Q Yan; S L Schmidt; W S Lane; E Querido; P E Branton; A Shilatifard; R C Conaway; J W Conaway
Journal:  J Biol Chem       Date:  2001-05-30       Impact factor: 5.157

4.  SOCS-6 negatively regulates T cell activation through targeting p56lck to proteasomal degradation.

Authors:  Young Bong Choi; Myoungsun Son; Mijin Park; Jaekyoon Shin; Yungdae Yun
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

5.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

6.  Genetic and pharmacologic evidence implicating the p85 alpha, but not p85 beta, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosis.

Authors:  Veerendra Munugalavadla; Emily C Sims; Jovencio Borneo; Rebecca J Chan; Reuben Kapur
Journal:  Blood       Date:  2007-05-04       Impact factor: 22.113

7.  Structural basis for activation of the receptor tyrosine kinase KIT by stem cell factor.

Authors:  Satoru Yuzawa; Yarden Opatowsky; Zhongtao Zhang; Valsan Mandiyan; Irit Lax; Joseph Schlessinger
Journal:  Cell       Date:  2007-07-27       Impact factor: 41.582

Review 8.  Scaling and assessment of data quality.

Authors:  Philip Evans
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2005-12-14

9.  Structure of the SOCS4-ElonginB/C complex reveals a distinct SOCS box interface and the molecular basis for SOCS-dependent EGFR degradation.

Authors:  Alex N Bullock; Maria C Rodriguez; Judit E Debreczeni; Zhou Songyang; Stefan Knapp
Journal:  Structure       Date:  2007-11       Impact factor: 5.006

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  28 in total

Review 1.  Cell regulation by phosphotyrosine-targeted ubiquitin ligases.

Authors:  Jonathan A Cooper; Tomonori Kaneko; Shawn S C Li
Journal:  Mol Cell Biol       Date:  2015-03-16       Impact factor: 4.272

2.  Surface Loops in a Single SH2 Domain Are Capable of Encoding the Spectrum of Specificity of the SH2 Family.

Authors:  Huadong Liu; Haiming Huang; Courtney Voss; Tomonori Kaneko; Wen Tao Qin; Sachdev Sidhu; Shawn S-C Li
Journal:  Mol Cell Proteomics       Date:  2018-11-27       Impact factor: 5.911

3.  Engineered SH2 domains with tailored specificities and enhanced affinities for phosphoproteome analysis.

Authors:  Gianluca Veggiani; Haiming Huang; Bradley P Yates; Jiefei Tong; Tomonori Kaneko; Rakesh Joshi; Shawn S C Li; Michael F Moran; Gerald Gish; Sachdev S Sidhu
Journal:  Protein Sci       Date:  2018-12-24       Impact factor: 6.725

4.  Defining an EPOR- regulated transcriptome for primary progenitors, including Tnfr-sf13c as a novel mediator of EPO- dependent erythroblast formation.

Authors:  Seema Singh; Arvind Dev; Rakesh Verma; Anamika Pradeep; Pradeep Sathyanarayana; Jennifer M Green; Aishwarya Narayanan; Don M Wojchowski
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

5.  Protein interaction screening for the ankyrin repeats and suppressor of cytokine signaling (SOCS) box (ASB) family identify Asb11 as a novel endoplasmic reticulum resident ubiquitin ligase.

Authors:  Christina Aaen Andresen; Stine Smedegaard; Kathrine Beck Sylvestersen; Charlotte Svensson; Diego Iglesias-Gato; Giuseppe Cazzamali; Tine Kragh Nielsen; Michael Lund Nielsen; Amilcar Flores-Morales
Journal:  J Biol Chem       Date:  2013-12-11       Impact factor: 5.157

Review 6.  Suppression of cytokine signaling: the SOCS perspective.

Authors:  Edmond M Linossi; Jeffrey J Babon; Douglas J Hilton; Sandra E Nicholson
Journal:  Cytokine Growth Factor Rev       Date:  2013-03-30       Impact factor: 7.638

7.  Suppressor of cytokine signaling 2 (SOCS2) associates with FLT3 and negatively regulates downstream signaling.

Authors:  Julhash U Kazi; Lars Rönnstrand
Journal:  Mol Oncol       Date:  2013-03-19       Impact factor: 6.603

Review 8.  Structural and functional properties of platelet-derived growth factor and stem cell factor receptors.

Authors:  Carl-Henrik Heldin; Johan Lennartsson
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-08-01       Impact factor: 10.005

Review 9.  SOCS6 is a selective suppressor of receptor tyrosine kinase signaling.

Authors:  Nuzhat N Kabir; Jianmin Sun; Lars Rönnstrand; Julhash U Kazi
Journal:  Tumour Biol       Date:  2014-08-30

Review 10.  SOCS proteins in regulation of receptor tyrosine kinase signaling.

Authors:  Julhash U Kazi; Nuzhat N Kabir; Amilcar Flores-Morales; Lars Rönnstrand
Journal:  Cell Mol Life Sci       Date:  2014-04-05       Impact factor: 9.261

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.